Illuminating the Black Box: The Real Risk of Serious Infection With Inflammatory Bowel Disease Therapies

被引：7
|
作者：
Lynn, Amanda M. [1 ]
Loftus, Edward V., Jr. [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St Southwest, Rochester, MN 55905 USA
来源：
GASTROENTEROLOGY | 2018年 / 155卷 / 02期
关键词：
CROHNS-DISEASE; COMBINATION THERAPY; INFLIXIMAB; AZATHIOPRINE;
D O I：
10.1053/j.gastro.2018.06.053
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：262 / 265
页数：4
相关论文
共 50 条
  • [41] RISK FACTORS FOR NON-ADHERENCE TO BIOLOGIC THERAPIES IN INFLAMMATORY BOWEL DISEASE
    Wentworth, Brian J.
    Buerlein, Ross C. D.
    Nakamura, Takahiro
    Tuskey, Anne G.
    Overby, M. Ashely
    Smolkin, Mark E.
    Behm, Brian W.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S59 - S59
  • [42] Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease
    Law, Cindy C. Y.
    Bell, Conor
    Koh, Deborah
    Bao, Yueyang
    Jairath, Vipul
    Narula, Neeraj
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (10):
  • [43] RISK FACTORS FOR NON-ADHERENCE TO BIOLOGIC THERAPIES IN INFLAMMATORY BOWEL DISEASE
    Wentworth, Brian J.
    Buerlein, Ross C. D.
    Nakamura, Takahiro
    Tuskey, Anne G.
    Overby, M. Ashely
    Smolkin, Mark E.
    Behm, Brian W.
    GASTROENTEROLOGY, 2018, 154 (01) : S84 - S84
  • [44] Contemporary Dietary Therapies in Inflammatory Bowel Disease
    Kaenkumchorn T.
    Musburger B.
    Suskind D.L.
    Current Treatment Options in Pediatrics, 2021, 7 (2) : 33 - 45
  • [45] New therapies for the treatment of inflammatory bowel disease
    Sands, Bruce E.
    SURGICAL CLINICS OF NORTH AMERICA, 2006, 86 (04) : 1045 - +
  • [46] Medical therapies for inflammatory bowel disease: An overview
    Lichtenstein, GR
    AUTOIMMUNE DISEASES IN PEDIATRIC GASTROENTEROLOGY, 2002, 127 : 124 - 144
  • [47] Positioning therapies for the management of inflammatory bowel disease
    Siddharth Singh
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 411 - 412
  • [48] Innovations in Oral Therapies for Inflammatory Bowel Disease
    Ma, Christopher
    Battat, Robert
    Dulai, Parambir S.
    Parker, Claire E.
    Sandborn, William J.
    Feagan, Brian G.
    Jairath, Vipul
    DRUGS, 2019, 79 (12) : 1321 - 1335
  • [49] Alternative and complementary therapies for inflammatory bowel disease
    Alfred Gangl
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 180 - 181
  • [50] Evaluation of new therapies for inflammatory bowel disease
    Carty, E
    Rampton, DS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 351 - 361
12345